{
    "nctId": "NCT00470574",
    "briefTitle": "Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer",
    "officialTitle": "Pilot Study of Immunization of High Risk Breast Cancer Patients With a Sialyl Lewis\u00aa -Keyhole Limpet Hemocyanin Conjugate Plus the Immunological Adjuvant QS-21",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 7,
    "primaryOutcomeMeasure": "Safety",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Histologically confirmed stage IV breast cancer meeting 1 of the following criteria:\n\n  * No evidence of disease\n  * Stable disease on hormonal therapy\n\n    * Stable disease must be present for \u2265 2 months and include \\< 30% decrease or \\< 20% increase in the sum of the longest diameter of target lesion\n    * No new target lesions or unequivocal progression of non-target lesions\n    * Elevation in the CA 153 (BR2729) or CEA values allowed\n* Hormone receptor status not specified\n\nPATIENT CHARACTERISTICS:\n\n* Female or male\n* Menopausal status not specified\n* Karnofsky performance status 80-100%\n* Lymphocyte count \u2265 500/mm\u00b3\n* WBC \u2265 3,000/mm\u00b3\n* Creatinine \u2264 1.5 times upper limit of normal (ULN)\n* AST \u2264 1.5 times ULN\n* Alkaline phosphatase \u2264 1.5 times ULN\n* Not pregnant or nursing\n* Negative pregnancy test\n* Fertile patients must use effective contraception\n* No history of allergy to seafood\n* No NYHA class III-IV cardiac disease\n* No other active cancers except basal cell or squamous cell carcinoma of the skin\n* No active infection requiring antibiotic treatment\n* No known history of immunodeficiency or autoimmune disease\n\nPRIOR CONCURRENT THERAPY:\n\n* See Disease Characteristics\n* At least 4 weeks since prior chemotherapy\n* At least 4 weeks since prior radiotherapy\n* At least 4 weeks since prior surgery\n* At least 6 weeks since prior immunotherapy\n* No prior sialyl Lewis\u00aa antigen\n* No concurrent immunosuppressive medications (i.e., corticosteroids)\n* Concurrent hormonal therapy allowed",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}